3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunoinflammatory Regulation of Esketamine in Septic Patients Esketamine hydrochloride - Esketamine, Sepsis | Phase 4 | Terminated | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 10 | 2021-07-28 | 2026-09-30 |
| Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation Envarsus Oral Product - Kidney Transplant Failure, Allosensitization | Phase 4 | Terminated | Imperial College Healthcare NHS Trust | 35 | 2018-11-01 | 2025-04-13 |
| Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status Tacrolimus - Immunosuppression | Phase 4 | Terminated | Weill Medical College of Cornell University | 34 | 2008-08-01 | 2019-06-12 |
Sepsis (1)
Infections (1) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1)
Tacrolimus (1)
Imperial College Healthcare NHS Trust (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Weill Medical College of Cornell University (1)
China (1) · United Kingdom (1) · United States (1)
Sandip Kapur, M.D. (1) · Shiying Yuan, PhD, MD (1)